< h2 > IARC Study Links 2.3 Million Global Cancer Cases to Infections in 2024 </ h2 > A new study by the International Agency for Research on Cancer (IARC) reveals that infections caused an estimated 2.3 million new cancer cases worldwide in 2024, accounting for 12% of all new cancer diagnoses. Published in The Lancet Oncology, the research highlights the significant role of infectious agents in cancer development and underscores opportunities for prevention through vaccination and treatment. The analysis, based on data from the IARC Global Cancer Observatory, includes newly identified infection-cancer associations and expands the list of cancers linked to infections.
< h2 > Key Pathogens and Regional Disparities </ h2 > The study identifies five major pathogens responsible for the majority of infection-related cancers: Helicobacter pylori (760,000 cases), human papillomavirus (HPV) (750,000 cases), hepatitis B virus (HBV) (360,000 cases), Epstein-Barr virus (EBV) (260,000 cases), and hepatitis C virus (HCV) (260,000 cases). H. pylori, a bacterium linked to stomach cancer, was most prevalent in eastern Asia, while HPV, which causes cervical cancer and other malignancies, was widespread in sub-Saharan Africa.
One in eight cancers worldwide linked to infections
Gary Clifford, a study co-author and cancer epidemiologist at IARC, noted that advancements in research have expanded understanding of infection-cancer links. "New infectious agents have been identified, and evidence has grown about the range of cancers caused by known pathogens," he said. The study also found that EBV, previously undercounted, contributes to nasopharyngeal cancer, gastric cancer, and Hodgkin’s lymphoma.
< h2 > Prevention Through Vaccination and Treatment </ h2 > The research emphasizes that many infection-related cancers are preventable. HPV vaccination, for example, has drastically reduced cervical cancer rates in countries like Australia, where HPV infections dropped by 90% among vaccinated populations. However, declining vaccination rates in recent years raise concerns about progress.
1 in 8 cancer cases worldwide are caused by
Antibiotics can mitigate cancer risk for H. pylori infections, while vaccines against HPV and HBV offer protection against multiple cancers. In Canada, infections account for 4% of cancer cases, with HPV vaccination programs credited for declining cervical cancer rates. Despite these successes, disparities persist, particularly in regions with limited access to screening and vaccines.
< h2 > Global Implications and Future Challenges </ h2 > The study underscores the need for targeted public health interventions to address infection-related cancers. Clifford highlighted that "these are actionable risk factors" requiring global collaboration. The findings align with previous IARC analyses, though data quality variations over time complicate direct comparisons across decades.
One in eight cancers are likely caused by an
As researchers continue to refine understanding of infection-cancer mechanisms, the focus remains on expanding prevention strategies. The IARC study serves as a call to action for policymakers and healthcare providers to prioritize vaccination, screening, and treatment access, particularly in low-resource settings where infection-related cancers are most prevalent.
< h2 > Source Details </ h2 > The study’s methodology and findings are detailed in Lancet Oncology. Additional context is provided by IARC’s press release.